Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study-Reference-Cited by-同舟云学术

Parecoxib prevents complications in hepatocellular carcinoma patients receiving hepatic transarterial chemoembolization: a prospective score-matched cohort study

Published:2016-04-02 Issue:19 Volume:7 Page:27938-27945
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhou Zhong-Guo¹,Chen Jin-Bin¹,Qiu Hai-Bo¹,Wang Ruo-Jing²,Chen Jian-Cong¹,Xu Li¹,Chen Min-Shan¹,Zhang Yao-Jun¹

Affiliation:

1. Sun Yat-Sen University Cancer Center, State Key Laboratory of Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, P.R. China

2. First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510060, P.R. China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK–VEGF/MMPs signaling pathway;IUBMB Life;2024-06-14

2. Downregulation of B7-H4 suppresses tumor progression of hepatocellular carcinoma;Scientific Reports;2019-10-16

3. Novel multimodal analgesia regimen improves post-TACE pain in patients with hepatocellular carcinoma;Hepatobiliary & Pancreatic Diseases International;2018-12

4. Health education helps to relieve postembolization pain during hepatic arterial chemoembolization therapy;Journal of Pain Research;2018-09

5. Efficacy of 125I Versus Non-125I Combined with Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma with Obstructive Jaundice;Digestive Diseases and Sciences;2018-01-05